Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Impel Pharmaceuticals

Impel Pharmaceuticals Announces Exploration of Strategic Alternatives
From Impel Pharmaceuticals
Via GlobeNewswire
Tickers IMPL
Impel Pharmaceuticals to Present New Real-World Data for Trudhesa® at the 65th Annual Scientific Meeting of the American Headache Society
From Impel Pharmaceuticals
Via GlobeNewswire
Tickers IMPL
Impel Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update
From Impel Pharmaceuticals
Via GlobeNewswire
Tickers IMPL
Impel Pharmaceuticals Announces Appointment of Michael W. Kalb as Chief Financial Officer
From Impel Pharmaceuticals
Via GlobeNewswire
Tickers IMPL
Impel Pharmaceuticals to Report First Quarter 2023 Financial Results on Friday, May 12, 2023
From Impel Pharmaceuticals
Via GlobeNewswire
Tickers IMPL
Impel Pharmaceuticals Presents New Data at AAN 2023 Suggesting Trudhesa® Nasal Spray is Safe to Use When Co-Administered With Commonly Prescribed Migraine Medications
From Impel Pharmaceuticals
Via GlobeNewswire
Tickers IMPL
Impel Pharmaceuticals Announces Appointment of Darren Cline to the Board of Directors
From Impel Pharmaceuticals
Via GlobeNewswire
Tickers IMPL
Impel Pharmaceuticals to Present Data on Trudhesa® Nasal Spray for Treatment of Acute Migraine at 2023 American Academy of Neurology Annual Meeting
From Impel Pharmaceuticals
Via GlobeNewswire
Tickers IMPL
Impel Pharmaceuticals Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
From Impel Pharmaceuticals
Via GlobeNewswire
Tickers IMPL
Impel Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results on Friday, March 24, 2023
From Impel Pharmaceuticals
Via GlobeNewswire
Tickers IMPL
Impel Pharmaceuticals to Participate in Upcoming Investor Conferences in March
From Impel Pharmaceuticals
Via GlobeNewswire
Tickers IMPL
Impel Pharmaceuticals Announces Strategic Repriortization, Continues Focus on Maximizing Trudhesa® Commercial Opportunity
From Impel Pharmaceuticals
Via GlobeNewswire
Tickers IMPL
Impel Pharmaceuticals Announces Third Quarter 2022 Financial Results and Provides Corporate Update
From Impel Pharmaceuticals
Via GlobeNewswire
Tickers IMPL
Impel Pharmaceuticals to Participate in Guggenheim 4th Annual Immunology and Neurology Day
From Impel Pharmaceuticals
Via GlobeNewswire
Tickers IMPL
Impel Pharmaceuticals to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022
From Impel Pharmaceuticals
Via GlobeNewswire
Tickers IMPL
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.